RE:Clinical Study data?If they are it's for a extended paycheck , biotechs are know to be Bold Face Liar's . The new CEO was a board memeber when they again destroyed shareholder value , with a outrageous 1for 60 on the reverse split and then the last cash raise and the shorting . But the COB of Promis is the same liar that issued 560 million shares for a paycheck , promised 3 to 4 partnerships and delivered nothing but bloated wages into his bank accounts .